TY  - GEN
AU  - Gane,Edward J
AU  - Shiffman,Mitchell L
AU  - Etzkorn,Kyle
AU  - Morelli,Giuseppe
AU  - Stedman,Catherine A M
AU  - Davis,Mitchell N
AU  - Hinestrosa,Federico
AU  - Dvory-Sobol,Hadas
AU  - Huang,K C
AU  - Osinusi,Anu
AU  - McNally,John
AU  - Brainard,Diana M
AU  - McHutchison,John G
AU  - Thompson,Alex J
AU  - Sulkowski,Mark S
TI  - Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen
SN  - 1527-3350
PY  - 2017///1004
KW  - Adult
KW  - Aged
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Carbamates
KW  - Drug Combinations
KW  - Drug Resistance, Viral
KW  - genetics
KW  - Drug Therapy, Combination
KW  - Female
KW  - Hepacivirus
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Heterocyclic Compounds, 4 or More Rings
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Ribavirin
KW  - Sofosbuvir
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/hep.29256
ER  -